CYS1 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the CYS1 protein, a member of a protein family involved in various cellular processes, particularly those related to the regulation of cysteine proteases. The CYS1 protein functions as a regulatory molecule, likely playing a role in modulating the activity of cysteine proteases, which are enzymes that cleave proteins at cysteine residues. These proteases are involved in a wide range of cellular functions, including protein degradation, cell signaling, and apoptosis. CYS1 is thought to act as a natural inhibitor or regulator of these proteases, helping to maintain the balance of proteolytic activity within the cell, which is crucial for cellular homeostasis and function.
Inhibitors of CYS1 are typically small molecules designed to bind specifically to the CYS1 protein, blocking its ability to interact with and regulate cysteine proteases. These inhibitors may function by binding to the active site or allosteric sites on the CYS1 protein, inducing conformational changes that diminish its regulatory capacity. The development of CYS1 inhibitors involves detailed structural analysis of the protein to identify key regions critical for its interaction with cysteine proteases. By inhibiting CYS1, researchers can explore its specific role in the regulation of proteolytic activity and how its inhibition affects broader cellular processes. The study of CYS1 inhibitors is essential for understanding the precise mechanisms through which CYS1 modulates protease activity and how this regulation impacts cellular processes such as protein turnover, signal transduction, and apoptosis. This research provides valuable insights into the complex regulatory networks that control protease activity and highlights the importance of CYS1 in maintaining the delicate balance of proteolytic processes essential for cellular function and integrity.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A phosphoinositide 3-kinase (PI3K) inhibitor that can prevent phosphorylation events, potentially affecting CYS1 if it is PI3K-regulated. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor that can interfere with stress-activated protein kinase signaling, potentially affecting CYS1 if it is involved in cellular stress responses. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor that can disrupt downstream signaling, potentially affecting CYS1 if it is involved in the PI3K/Akt pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that can block c-Jun N-terminal kinase pathways, potentially affecting CYS1 if it is regulated by JNK signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can disrupt cellular growth and proliferation signaling, potentially affecting CYS1 if it is involved in mTOR pathways. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
A Hedgehog signaling pathway inhibitor that can affect cell differentiation and tissue patterning, potentially affecting CYS1 if it is part of this pathway. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $74.00 | 256 | |
A pan-caspase inhibitor that can block apoptosis, potentially affecting CYS1 if it has a role in programmed cell death. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
An inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), potentially affecting CYS1 if it is Ca2+ sensitive. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
A glycolysis inhibitor that can interfere with energy metabolism, potentially affecting CYS1 if its function is energy-dependent. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
An inhibitor of Golgi apparatus function that can disrupt protein trafficking, potentially affecting CYS1 if it undergoes Golgi-mediated processing. |